Under pressure over rising drug prices, pharmaceutical companies are pushing a new defense: They’re not raising prices to make money or to cover research costs, but rather to pay a cut to middlemen in the supply chain.
from WSJ.com: What's News US https://on.wsj.com/2Se0Woj
Tuesday, 5 February 2019
Related Post
Trump Administration Plans Effort to Let States Remodel MedicaidThe Trump administration is readying guidance that could let states remodel their Medicaid programs
Marine Recruits Learn an Important Lesson: What Happened on 9/11The U.S. war in Afghanistan has been going on for so long that the newest recruits weren’t alive wh
Stocks Fall Sharply as Nasdaq Closes Near Bear MarketThe Nasdaq Composite Index tumbled and threatened to enter a bear market as the Federal Reserve’s l
Small Businesses Are Waving the Caution FlagAfter a banner year, many small businesses are becoming more cautious about their investment and hi
Car Sales Keep Pace in 2018, Defying Predictions of a DownturnThe industry sold about 17.3 million vehicles in 2018, up less than 1% from a year earlier. That ma
How China Built a Steel Behemoth and Convulsed World TradeA four-decade drive, driven by global demand and supported by government subsidies, cheap loans and
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment
Click to see the code!
To insert emoticon you must added at least one space before the code.